|
| Press Releases |
|
 |
|
| Wednesday, March 20, 2024 |
|
|
Hengdeli Announces 2023 Annual Results |
Hengdeli Holdings Limited ("Hengdeli" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 3389) announced its annual results for the twelve months ended 31 December 2023 ("the year under review").
more info >> |
|
| Tuesday, August 22, 2023 |
|
|
Hengdeli narrowed its loss by 91.3% in 1H2023 |
| Hengdeli Holdings Limited (3389) announced its interim results for the six months ended 30 June 2023. During the period under review, the Group recorded revenue of RMB675,621,000, representing a year-on-year increase of 20.9% more info >> |
|
| Tuesday, March 21, 2023 |
|
|
亨得利2022全年业绩发布 |
亨得利控股有限公司（「亨得利」或「公司」及其子公司「集团」，股票编号：3389）宣布截至2022年12月31日止12个月（「回顾年内」）之全年业绩。
more info >> |
|
|
亨得利2022全年業績發佈 |
| 亨得利控股有限公司（「亨得利」或「公司」及其子公司「集團」，股票編號：3389）宣佈截至2022年12月31日止12個月（「回顧年內」）之全年業績。 more info >> |
|
|
Hengdeli Announces 2022 Annual Results |
| Hengdeli Holdings Limited ("Hengdeli" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 3389) announced its annual results for the twelve months ended 31 December 2022 ("the year under review"). more info >> |
|
| Tuesday, August 30, 2022 |
|
|
亨得利2022年中期业绩发布：创新发展 行稳致远 |
| 亨得利控股有限公司（「亨得利」或「公司」及其子公司「集团」，股票代号：3389）宣布截至2022年6月30日止6个月（「回顾期内」）之中期业绩。 more info >> |
|
|
亨得利2022年中期業績發佈：創新發展 行穩致遠 |
| 亨得利控股有限公司（「亨得利」或「公司」及其子公司「集團」，股票代號：3389）宣佈截至2022年6月30日止6個月（「回顧期內」）之中期業績。 more info >> |
|
|
Hengdeli Announces 2022 Interim Results: Innovative Development and Long-Term Operations |
| Hengdeli Holdings Limited ("Hengdeli" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 3389), a high-end consuming accessories manufacturer and international bulk commodity trade group, announced its interim results for the six months ended 30 June 2022 ("the period under review"). more info >> |
|
| Tuesday, March 23, 2021 |
|
|
亨得利2020全年业绩发布 |
| 国际名表销售及手表配套产品制造集团 - 亨得利控股有限公司 （「亨得利」或「公司」及其子公司「集团」，股票编号：3389）宣布截至2020年12月31日止12个月（「回顾年内」）之全年业绩。 more info >> |
|
|
亨得利2020全年業績發佈 |
| 國際名錶銷售及手錶配套產品製造集團 - 亨得利控股有限公司 （「亨得利」或「公司」及其子公司「集團」，股票編號：3389）宣佈截至2020年12月31日止12個月（「回顧年內」）之全年業績。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
維昇藥業（2561.HK）維臻高(R)獲批：重長效生長激素王者登場 重構百億市場的商業天花板
Feb 25, 2026 14:58 HKT/SGT
|
|
|
Hong Kong Tech Delegation Heading for Market Expansion at Mobile World Congress 2026
Feb 25, 2026 14:54 HKT/SGT
|
|
|
CanSinoBIO's Menhycia (R) Secures Expanded Age Indication, Unlock Broader Long-Term Growth Potential
Feb 25, 2026 12:46 HKT/SGT
|
|
|
Shoucheng Holdings (00697.HK) Sees Long-Term International Capital Rotation as Robotics Portfolio Enters Harvest Phase
Feb 25, 2026 12:23 HKT/SGT
|
|
|
首程控股（00697.HK）迎來國際長線接盤 機器人產業生態進入價值收割期
Feb 25, 2026 12:23 HKT/SGT
|
|
|
首程控股（00697.HK）迎来国际长线接盘 机器人产业生态进入价值收割期
Feb 25, 2026 12:23 HKT/SGT
|
|
|
ベイシアのスーパーマーケット内の冷蔵・冷凍庫の温度点検・記録業務を富士通のIoT可視化ソリューションにより自動化
Feb 25, 2026 12:00: JST
|
|
|
Beisia Automates Supermarket Refrigerator Temperature Monitoring and Recording with Fujitsu's IoT Visualization Solution
Feb 25, 2026 12:00 JST
|
|
|
國泰君安國際獲批使用SIMM 衍生品風險管理接軌國際標準
Feb 25, 2026 10:34 HKT/SGT
|
|
|
国泰君安国际获批使用SIMM 衍生品风险管理接轨国际标准
Feb 25, 2026 10:34 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 22:30: JST
|
|
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 21:30 HKT/SGT
|
|
|
TANAKA to Provide Medals for the Tokyo Marathon 2026 That Represent All the Participants in the Event with Woven Lines
Feb 24, 2026 22:00 JST
|
|
|
康哲藥業（867.HK/8A8.SG）：創新藥磷酸蘆可替尼乳膏增加特應性皮炎（AD）適應症中國上市許可申請獲受理並獲納入優先審評
Feb 24, 2026 20:31 HKT/SGT
|
|
|
康哲药业（867.HK/8A8.SG）：创新药磷酸芦可替尼乳膏增加特应性皮炎（AD）适应症中国上市许可申请获受理并获纳入优先审评
Feb 24, 2026 20:19 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
